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The development of nanoscopic hybrid materials equipped
with “molecular gates” showing the ability of releasing target
entrapped guests upon the application of an external trigger
has attracted great attention and has been extensively ex-
plored during recent years.
[1] These nanodevices are composed
of two subunits, namely, a suitable support and certain cap-
ping entities grafted on the surface of the scaffolding.
[2] The
support is used as a suitable reservoir in which certain chemi-
cals can be stored whereas the molecules grafted in the outer
surface act as a “gate” and can control the release of the en-
trapped molecules at will. Both components are carefully se-
lected and arranged in order to achieve a wide range of re-
quired functionalities.
As support, mesoporous silica nanoparticles (MSN) have
been widely used due to their unique properties, such as large
load capacity, biocompatibility, high surface area and well-
known functionalization procedures.
[3] Moreover, gated MSN
have recently been used for the development of on-command
delivery nanodevices by using several physical and chemical
triggers. For instance, MSN displaying controlled-release fea-
tures with the use of light,
[4] redox reactions,
[5] and pH
changes
[6] have been described. In contrast, gated nanomateri-
als able to deliver the cargo triggered by biomolecules are
scarce although some illustrative examples that use antigen–
antibody interactions,
[7] hybridisation of single stranded oligo-
nucleotides,
[8] and enzymes
[9–14] have been reported. In particu-
lar, the use of enzymes is especially appealing taking into ac-
count the possibility to synthesise tailor-made enzyme-specific
sequences as molecular caps. However, in spite of these inter-
esting features there are few examples that use enzymes in
opening protocols. The first enzyme-responsive gate in a mes-
oporous support was described by Stoddart and co-workers. In
that work, a [2]rotaxane ended with a bulky adamantyl ester
stopper that acted as molecular gate was removed by porcine
liver esterase treatment.
[9] Further hybrid systems involving
avidin–biotin,
[10] lactose,
[11] starch,
[12] b-cyclodextrins
[13] and pep-
tide sequences
[14] as capping groups have been reported.
These examples offer a chemically simple approach that can
benefit from the vast knowledge on enzyme–substrate pairs
for the design of versatile systems for controlled release.
A further step in the field should take into account that the
flow of defined biological processes rely on biochemical net-
works with the participation of multiple enzyme-dependent
stages. It would be then useful to define future applications
with the development of dual or multiple enzyme-triggered
systems by using capped mesoporous supports. This would re-
quire the design of capping threads containing different
enzyme-specific hydrolysable linkers located at defined posi-
tions on the external surface of MSN. The whole design will
provide highly versatile and specific-release nanodevices the
delivery profiles of which could be controlled and fine-tuned
by defined combinations of enzymes. As a first-of-its-kind
proof-of-concept, we have prepared an MSN support capped
with the molecular entity 1 that contains amide and urea link-
ages, and we have evaluated it as a multi-enzyme-tuned deliv-
ery system (Scheme 1).
As inorganic carrier vehicle we selected mesoporous MCM-
41 silica nanoparticles of about 100 nm in diameter, which
were prepared following well-known procedures using TEOS as
hydrolytic inorganic precursor and hexadecyltrimethylammoni-
um bromide (CTABr) as porogen species.
[15] The structure of
the nanoparticulated calcined MCM-41 starting material was
confirmed by X-ray diffraction (Figure 1), TEM and SEM micros-
copy. The N2 adsorption–desorption isotherms showed a typi-
cal type IV curve with a specific surface of 999.6 m
2g
1, and a
pore volume of 0.79 cm
3g
1. From the XRD, porosimetry and
TEM studies, the a0 cell parameter (4.44 nm), the pore diameter
(2.46 nm) and a value for the wall thickness (1.99 nm) were cal-
culated. For the preparation of S1, the calcinated MSN was
first loaded with [Ru(bipy)3]Cl2, which was used as dye for
monitoring the enzyme-triggered protocol, and then treated
with the capping molecule 1. The derivative 1 was synthesised
following a two-step procedure from diethylentriamine. In a
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were selectively amidated with pivaloyl anhydride at 08C.
[16] In
a second step, the free secondary amine was treated with (3-
isocyanatopropyl)triethoxysilane in the presence of K2CO3 to
yield the final trialcoxysilane derivative 1 (see the Supporting
Information for experimental details).
The prepared solid S1 was characterised by using standard
techniques. S1 displays expected features of the MCM-41
phase, as can be observed in the TEM image shown in
Figure 1. This suggests that loading and grafting procedures
did not modify the mesoporous structure of the starting mate-
rial. Additionally the N2 adsorption–desorption isotherm of S1
was typical of mesoporous systems with filled mesopores, and
a significant decrease in the N2 volume adsorbed and the sur-
face area (696.5 m
2g
1) was observed. The content of rutheni-
um complex and capping molecule 1 in the final solid S1 were
determined by thermogravimetric and elemental analysis and
amounted to 0.15 and 0.22 mmolg
1 SiO2, respectively.
The presence of amide and urea moieties in the capping
molecule 1 allowed the analysis of a multi-enzyme-dependent
release of the [Ru(bipy)3]
2+ dye from S1 by using amidase and
urease enzymes. In a typical experiment, solid S1 (5 mg) was
suspended in water (12.5 mL) at pH 7.5. Then amidase or/and
urease (1 mL of the purchased solution) were added and the
final suspension was stirred. As the control experiment dye re-
lease was determined by using suspensions of S1 under similar
conditions but in the absence of enzyme. Uncapping and sub-
sequent delivery of the dye to the aqueous solution was easily
detected by monitoring the metal-to-ligand charge transfer
transition band of the [Ru(bipy)3]
2+ dye at 451 nm or through
the emission band at 619 nm (lex=451 nm).
[17] The different
delivery profiles for both experiments are shown in Figure 2. In
the presence of amidase a relatively quick delivery was found
(ca. 20% of the cargo was released in 2 h); however, only a
moderate delivery was observed for long periods of time (only
40% of the dye was delivered after 15 h). In contrast the
urease-stimulated release was slower (for instance, no delivery
was observed after 2.5 h) yet at longer time periods urease
was able to deliver a significantly larger amount of the cargo
from S1 (ca. 80% of the dye was delivered after 15 h) than
amidase. We also observed that there is a very low payload re-
lease in the absence of urease or amidase (Figure 2).
The different enzyme-dependent delivery rates obtained on
solid S1 were related to the design of gate 1, in particular to
the relative position of the hydrolysable groups on the mole-
cule. Solid S1 treatment with amidase induced the hydrolysis
of the amide bonds located far away from the surface with the
subsequent release of two bulky trimethylacetate moieties. In
spite of this reduction in the steric crowding around the pore
outlets, the organic residual that remained anchored was large
enough to hamper, to some extent, the release of the dye. As
a consequence, the degree of cargo release is low but fast. On
changing from amidase to urease a completely different re-
sponse was obtained. Addition of urease induced the hydroly-
sis of the urea bond located deeper inside the structure of 1
and led to a drastic reduction of the thread size. As a conse-
quence, the degree of cargo release is high but quite slow.
Release experiments with S1 in the presence of both en-
zymes were also carried out. In this case, a synergic effect was
Scheme 1. Schematic representation of solid S1 and the enzymatic uncap-
ping mechanism.
Figure 1. Left: powder X-ray patterns of: a) solid S1, b) calcined MCM-41,
and c) MCM-41 as-synthesised. Right: TEM images of: d) solid S1, and e) cal-
cined MCM-41 sample showing the typical hexagonal porosity of the MCM-
41 mesoporous matrix.
Figure 2. Kinetics of the release of [Ru(bipy)3]
2+ dye from solid S1 in the
presence of amidase and urease.
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lease, whereas at longer time periods the combined action of
the urease allows a nearly complete cargo delivery (see the
Supporting Information). In order to further demonstrate that
the enzyme treatment is entirely responsible for the cargo re-
lease, two additional experiments were carried out. Solid S1
was incubated in the presence of non-related enzymes, such
as esterase and pronase. In a different experiment, prior to in-
cubation with solid S1, the amidase and urease were heat de-
natured at 608C for 60 min. In both experiments no release of
the dye was observed.
Once we demonstrated the in vitro aperture mechanism of
S1, our next objective was to test the feasibility of using this
gated nanodispositive in cells. For this purpose, the HeLa cell
line was chosen and treated with S1 at different doses for
24 h. Cell viability and cellular uptake of nanoparticles was as-
sessed by using the WST-1 assay and confocal microscopy
(Figure 3).
[12] The same experiments were also performed by
using the MCF-7 cell line (see the Supporting Information for
further details). Confocal images demonstrated that the intra-
cellular vesicular localization of S1 nanoparticles (red) is proba-
bly associated to lysosomes. Also, S1 solid was biocompatible
at the concentrations tested as no significant reduction in cell
viability was observed.
With the aim to demonstrate a possible therapeutic applica-
tion of these nanodevices as drug carriers, a new S1 solid was
synthesised containing the chemotherapeutic agent campto-
thecin (CPT). CPT is a cytotoxic quinoline alkaloid that inhibits
DNA polymerase I and disrupts DNA replication to induce cell
death. HeLa cells were treated as described before in the pres-
ence of this new material, S1-CPT.
In order to obtain a more detailed analysis of the cell death
processes related to the in-cell release of CPT from the nano-
particles, the dye propidium iodide (PI) and the early stage cell
death marker Annexin V (Ann V) were employed (see the Sup-
porting Information for further details). Figure 4 shows the re-
sults obtained by confocal microscopy and flow cytometry. A
significant reduction in cell viability was observed 24 h after
the addition of S1-CPT by confocal microscopy studies (cells
detached from the plate, plasma membrane blebbling, and
presence of cellular debris, among other features). These re-
sults were confirmed by flow cytometry experiments. Just 24 h
after the addition of S1-CPT (200 mgmL
1) 50% of the cells
were dead and 25% had initiated cell death processes. By con-
trast, no significant reduction in cell viability was observed
when cells were treated with S1-E, an S1 solid with no cargo
molecule (see the Supporting Information for further details).
In summary, we have reported here the synthesis of new
nanoscopic silica mesoporous supports capped with enzyme
hydrolysable groups for the design of nanodevices for zero re-
lease that are specifically opened in the presence of defined
enzymes. In particular we have designed gated materials
capped with bulky organic moieties containing amide and
urea linkages that could be selectively hydrolysed in the pres-
Figure 3. A) Confocal microscopy images corresponding to HeLa cells treat-
ed with solid S1 (100 mgmL
1). The cellular uptake of S1 was followed by
[Ru(bipy)3]
2+ associated fluorescence (red) in the presence of DNA marker
Hoechst 33342 (blue) and the plasma membrane marker WGA-Alexa-
Fluor 647 (green). B) For viability studies, cells were treated with S1 and
after 24 h incubation, WST-1 reagent was added and cell viability was mea-
sured.
Figure 4. Cell death induction by S1-CPT: A), B) HeLa cells were treated with
200 mgmL
1 of S1-CPT or S1-E (S1 without cargo) for 24 h and then flow cy-
tometry studies and quantification of viable (white) and dead cells was per-
formed by PI (black) and Ann V (grey) staining. Two independent experi-
ments containing duplicates were performed. Statistically significant differ-
ences were observed (P<0.05, Student’s t-test). C) Cellular internalisation
and release of the cargo of S1-CPT was followed by confocal microscopy
(blue) in the presence of the plasma membrane marker WGA-AlexaFluor 647
(green); scale bar: 50 mm.
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delivery profile was observed depending on the enzyme used.
Amidase induced the hydrolysis of two amide bonds located
far away from the inorganic support; this allowed immediate,
yet incomplete, release of the dye. In contrast, urease hydro-
lysed the urea bond located deeper inside the capping mole-
cule and closer to the surface of the silica nanoparticle; this al-
lowed a near total cargo release but was delayed in time. Si-
multaneous treatment with both enzymes displayed a syner-
gistic effect and a delivery profile showing fast and complete
payload release was observed. These results demonstrate that
it is possible to use relatively simple molecules containing
enzyme-hydrolysable groups for the design of versatile capped
materials that can be opened at will.
The possibility of including, in the capping molecule, differ-
ent enzyme-hydrolysable groups located in predefined posi-
tions allows the control of the delivery profiles. Based on the
fact that enzyme–substrate pairs offer a vast range of combi-
nations, proof-of-concept of the possible application of this
nanodevice as drug carrier was performed and proved the abil-
ity of the S1-CPT solid to be internalized by cells and release
its cargo. We believe that the design of multi-enzyme-respon-
sive capped materials can be important in the design of
custom-made systems for delivery applications with the aim of
controlling the flow of key biological processes in nano- and
regenerative medicine.
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